Vésale Bioscience receives €1.8M grant for AMR phage project
Belgian company Vésale Bioscience has received €1.8 million ($1.9 million) in grants from the European…
Get the latest news of biotech in Belgium. Learn more about the latest regulations, collaboration deals, and technology advancements of Belgian biotech companies.
Belgian company Vésale Bioscience has received €1.8 million ($1.9 million) in grants from the European…
ExeVir Bio, a Belgian biotech company developing nanobody therapies for broad protection against infectious diseases,…
PDC*line Pharma, a clinical stage biotech company has announced the first immunological results of its…
Novadip Biosciences SA has announced positive data from its phase 1/2 clinical trial evaluating the…
Polyplus has announced the completion of an acquisition of Belgian Xpress Biologics to expand plasmid…
UCB has announced the publication of long-term open-label extension (OLE) study results of FINTEPLA (fenfluramine)…
Sequana Medical has had some very positive top-line results from a phase 2a study, that…
BioSenic’s systemic autoimmune disease platform, originally designed by Medsenic, is now developing controlled dosages and…
Novadip Biosciences has raised an additional €40 million ($39.2 million) in a series B equity…
This week, we have three interviews, and four guests. We chatted with Keith Fargo, chief…
Domain Therapeutics says its immuno-oncology candidate has been cleared in Belgium and France, leading to…
Biocartis Group NV has started the commercialization in Europe of the HepatoPredict test as a…